• Explore /
  • Poster
  • / High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunoscore and pCR in the Averectal study.

High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunoscore and pCR in the Averectal study.

Abstract Poster

Authors

null

Ali Shamseddine

American University of Beirut Medical Center, Beirut, Lebanon

Ali Shamseddine , Ibrahim Moustafa Khalifeh , Charbel Elias , Rim Turfa , Joseph Gergi Kattan , Deborah Mukherji , Sally Naji Temraz , Kholoud Alqasem , Rula Amarin , Tala Alawabdeh , Samer Deeba , Issa Mohamad , Faiez Daoud , Mahmoud Al Masri , Ali Dabous , Ahmad Hushki , Omar Jaber , Maya Charafeddine , Lama Farhat , Ayman Tawil

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT03503630

DOI

10.1200/JCO.2022.40.4_suppl.184

Abstract #

184

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ali Shamseddine

First Author: Ali Shamseddine

Poster

2020 Gastrointestinal Cancers Symposium

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.

Short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.

First Author: Ali Shamseddine

First Author: Felipe Fernando Quezada